Amarpreet Sawhney Ph.D. — Founder & Executive Chairman at Ocular Therapeutix | Comparably
Ocular Therapeutix Claimed Company
Ocular Therapeutix develops and commercializes ophthalmic therapeutic products by using hydrogel technology. read more
EMPLOYEE
PARTICIPANTS
53
TOTAL
RATINGS
988
HR or Marketing? Claim Your Free Employer Account
Amarpreet Sawhney Ph.D. — Founder & Executive Chairman at Ocular Therapeutix

Amarpreet Sawhney Ph.D. — Founder & Executive Chairman at Ocular Therapeutix

Executive Bio

Dr. Amarpreet Sawhney, also known as Amar, Ph.D. is a Co-Founder and Managing Partner of Incept, LLC. Dr. Sawhney founded Ocular Therapeutix, Inc in November 2006 has been its Executive Chairman since June 2014. Dr. Sawhney served as Chief Executive Officer and President at Ocular Therapeutix, Inc since 2006 until 2017. He served as an Advisor at Axtria, Inc. He served as the President and Chief Executive Officer at Confluent Surgical, Inc. He is the President and Chief Executive Officer at Octux, Inc. He founded Augmenix, Inc. and also served as its Chief Executive Officer and President. He is the Founder, Chief Executive Officer and President at Ocular Therapeutix Inc. He founded Access Closure, Inc. and Octux, Inc. He co-founded Confluent Surgical, Inc. in 1998. Dr. Sawhney was the Technology Founder at Focal Inc. of Lexington, Massachusetts (acquired by Genzyme). He co-invented Novacell of Santa Ana, California. He serves as the Chairman of Augmenix, Inc. He served as the Chairman of marketRx, Inc. He serves as Executive Director for Instylla, Inc. He has been a Director of Ocular Therapeutix, Inc. since 2006. He serves as a Director of Axtria, Inc. He serves as a Director of Confluent Surgical, Inc. and marketRx, Inc. Dr. Sawhney served as Board Member of Octux, Inc., Augmenix, Inc., and Incept LLC. He served as a Director of Access Closure, Inc. and Focal Inc. He personally holds over 35 patents and has authored over 85 publications and scientific abstracts. He has been recognized by several awards including the MIT Global Indus Technovators award and the E&Y Regional Entrepreneur of the year award. His innovations are the subject of almost 100 issued and pending patents in biomaterials. His inventions include ???first-of-a-kind??? surgical sealants to be approved by the Food and Drug Administration. Dr. Sawhney holds a Ph.D. and a M.S. in Chemical Engineering from the University of Texas at Austin. He holds a B. Tech. in Chemical Engineering from the Indian Institute of Technology, New Delhi.
Name
Title
Salary
Total Comp Total Compensation includes both short-term and long-term benefits, option grants, salary, bonuses, company perks, etc. that can be used to determine financial benefits. An executive may or may not realize all of the Total Co mpensation during their tenure at the Company. Values of the benefits may change over time.
Founder & Executive Chairman
$779k
$1.75M

Executive Team Culture Ratings from Ocular Therapeutix Employees

TOP
5%
Ocular Therapeutix's Executive Team scores in the Top 5%
of similar sized companies on Comparably
Who ranks the Executive Team the highest?
Experience - 3 to 6 Years 98/100
Department - Sales 97/100
Department - Engineering 97/100
Who ranks the Executive Team the lowest?
Department - Operations 81/100
Ethnicity - Asian or Pacific Islander 86/100
Gender - Male 87/100

Ocular Therapeutix's Executive Team at a Glance

Based on 53 ratings, Ocular Therapeutix's employees are very satisfied with their Executive Team and give them an ā€œA+ā€ or 89/100. On average, Women provided higher ratings for their Executive Team compared to Men.

Ocular Therapeutix's Executive Team ranks in the Top 5% of other companies in Boston and Top 5% of other companies on Comparably that also have 51-200 Employees.

×
Rate your company